STERIS plc $STE Stock Position Boosted by Copeland Capital Management LLC

Copeland Capital Management LLC boosted its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 13.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 177,778 shares of the medical equipment provider's stock after acquiring an additional 21,353 shares during the quarter. Copeland Capital Management LLC owned 0.18% of STERIS worth $37,335,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Krilogy Financial LLC increased its stake in STERIS by 35.2% in the third quarter. Krilogy Financial LLC now owns 2,978 shares of the medical equipment provider's stock worth $652,000 after purchasing an additional 776 shares during the period. NorthCrest Asset Manangement LLC boosted its stake in shares of STERIS by 9.0% during the third quarter. NorthCrest Asset Manangement LLC now owns 2,539 shares of the medical equipment provider's stock valued at $535,000 after purchasing an additional 210 shares during the period. Perpetual Ltd boosted its stake in shares of STERIS by 9.5% during the third quarter. Perpetual Ltd now owns 69,157 shares of the medical equipment provider's stock valued at $14,524,000 after purchasing an additional 5,974 shares during the period. GK Wealth Management LLC purchased a new stake in shares of STERIS during the third quarter valued at $88,000. Finally, Wedmont Private Capital boosted its stake in shares of STERIS by 30.2% during the third quarter. Wedmont Private Capital now owns 1,264 shares of the medical equipment provider's stock valued at $266,000 after purchasing an additional 293 shares during the period. Hedge funds and other institutional investors own 94.69% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on STE shares. UBS Group reduced their price target on shares of STERIS from $275.00 to $270.00 and set a "buy" rating on the stock in a research note on Friday, August 7th. Wall Street Zen lowered shares of STERIS from a "strong-buy" rating to a "buy" rating in a report on Sunday. Weiss Ratings reissued a "hold (c)" rating on shares of STERIS in a research report on Monday, August 24th. Finally, Piper Sandler restated an "overweight" rating and issued a $275.00 target price (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $271.33.

Insiders Place Their Bets

In other news, Director Mohsen Sohi sold 4,058 shares of STERIS stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total value of $956,795.24. Following the transaction, the director directly owned 24,305 shares in the company, valued at approximately $5,730,632.90. This trade represents a 14.31% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.12% of the stock is currently owned by corporate insiders.

STERIS Trading Down 0.6%

Shares of NYSE STE opened at $217.66 on Wednesday. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23. The business has a fifty day simple moving average of $221.84 and a two-hundred day simple moving average of $217.89. The firm has a market cap of $21.22 billion, a PE ratio of 21.01 and a beta of 0.92. STERIS plc has a twelve month low of $195.14 and a twelve month high of $269.44.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.49 by $0.10. STERIS had a return on equity of 14.34% and a net margin of 13.34%. The business had revenue of $1.49 billion during the quarter, compared to analysts' expectations of $1.49 billion. During the same period in the prior year, the business earned $2.34 EPS. The business's revenue for the quarter was up 7.3% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Analysts expect that STERIS plc will post 11.12 earnings per share for the current fiscal year.

STERIS Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Friday, September 4th were issued a dividend of $0.69 per share. This is an increase from STERIS's previous quarterly dividend of $0.63. This represents a $2.76 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date was Friday, September 4th. STERIS's dividend payout ratio (DPR) is currently 33.74%.

About STERIS

STERIS plc NYSE: STE provides products and services designed to support infection prevention, surgical procedures, and the manufacture of healthcare and pharmaceutical products. The company serves healthcare providers, pharmaceutical and biotechnology manufacturers, and other organizations that require controlled, sterile environments.

Its Healthcare segment offers sterilization and decontamination equipment, operating-room products, surgical instruments, endoscopy products, consumables, and related maintenance and procedural services.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.